Overview
Katalin Karikó is a mrna therapeutics specialist with an H-index of 150 at University of Pennsylvania (Faculty). Has been published in Nature reviews. Drug discovery, Nature, Science (New York, N.Y.). Based in United States.
Biography
Katalin "Kati" Karikó is a Hungarian-American biochemist who specializes in ribonucleic acid (RNA)-mediated mechanisms, particularly in vitro-transcribed messenger RNA (mRNA) for protein replacement therapy. Karikó laid the scientific groundwork for mRNA vaccines, overcoming major obstacles and skepticism in the scientific community. Karikó received the Nobel Prize in Physiology or Medicine in 2023 for her work, along with American immunologist Drew Weissman.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Publication Timeline
Published In
ImmunityMol TherScienceNat Rev Drug Discov
Key Publications
Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.
Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.
mRNA-based therapeutics--developing a new class of drugs.
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.
Areas of Expertise
Medical Specialties
Media Archive